Literature DB >> 1346581

Sulphasalazine induced autoimmune syndrome.

T Vyse1, A K So.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346581     DOI: 10.1093/rheumatology/31.2.115

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


× No keyword cloud information.
  7 in total

Review 1.  Drug-induced lupus anticoagulants and antiphospholipid antibodies.

Authors:  Jeffrey S Dlott; Robert A S Roubey
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

2.  The three week sulphasalazine syndrome.

Authors:  H Brooks; H G Taylor; F E Nichol
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

3.  Drug-related lupus in a patient with rheumatoid arthritis under sulfasalazine treatment.

Authors:  K Wildhagen; K Hartung; M Hammer; W Mau; R E Schmidt; H Deicher; H Zeidler
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

Review 4.  Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.

Authors:  C P Rains; S Noble; D Faulds
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

5.  Combination therapy for rheumatoid arthritis and drug-induced systemic lupus erythematosus.

Authors:  A A Borg; M J Davis; P T Dawes; M F Shadforth
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

Review 6.  A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.

Authors:  A A Kalla; A F Tooke; E Bhettay; O L Meyers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

Review 7.  Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation.

Authors:  Anush Martirosyan; Rustam Aminov; Gayane Manukyan
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.